AnaptysBio Inc (NASDAQ: ANAB) on Monday, plunged -14.30% from the previous trading day, before settling in for the closing price of $39.65. Within the past 52 weeks, ANAB’s price has moved between $12.21 and $40.96.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -7.30%. The company achieved an average annual earnings per share of 62.09%. With a float of $25.31 million, this company’s outstanding shares have now reached $27.58 million.
AnaptysBio Inc (ANAB) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of AnaptysBio Inc is 8.58%, while institutional ownership is 128.47%. The most recent insider transaction that took place on Sep 30 ’25, was worth 238,960. In this transaction CHIEF LEGAL OFFICER of this company sold 8,240 shares at a rate of $29.00, taking the stock ownership to the 9,088 shares. Before that another transaction happened on Sep 30 ’25, when Company’s Officer proposed sale 8,240 for $29.00, making the entire transaction worth $238,960.
AnaptysBio Inc (ANAB) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.72 earnings per share (EPS) for the period topping the consensus outlook (set at -1.7) by 0.98. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.96% during the next five years compared to -7.30% drop over the previous five years of trading.
AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators
AnaptysBio Inc (ANAB) is currently performing well based on its current performance indicators. A quick ratio of 8.68 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.82, a number that is poised to hit 0.54 in the next quarter and is forecasted to reach -4.25 in one year’s time.
Technical Analysis of AnaptysBio Inc (ANAB)
The latest stats from [AnaptysBio Inc, ANAB] show that its last 5-days average volume of 0.85 million was superior to 0.71 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.14%.
During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 70.74%, which indicates a significant increase from 34.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.52 in the past 14 days, which was higher than the 1.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.09, while its 200-day Moving Average is $22.64. Now, the first resistance to watch is $36.43. This is followed by the second major resistance level at $38.88. The third major resistance level sits at $41.96. If the price goes on to break the first support level at $30.90, it is likely to go to the next support level at $27.82. Assuming the price breaks the second support level, the third support level stands at $25.37.
AnaptysBio Inc (NASDAQ: ANAB) Key Stats
Market capitalization of the company is 940.86 million based on 27,688K outstanding shares. Right now, sales total 91,280 K and income totals -145,230 K. The company made 22,260 K in profit during its latest quarter, and -38,630 K in sales during its previous quarter.
